TDOC vs RXRX

Comparison between Teladoc Health Inc (TDOC, Company) and Recursion Pharmaceuticals Inc - Class A (RXRX, Company).

Both TDOC and RXRX are from the Healthcare sector.

5-Year PerformanceRXRX has outperformed TDOC, delivering a return of -38.8% compared to -42.4%

TDOC vs RXRX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	TDOC(COMPANY)	RXRX(COMPANY)
Market Cap	$1.75B	$1.76B
Max Drawdown	98.48%	93.13%
Sharpe Ratio	0.54	-0.61
5Y Beta	1.40	2.63
Industry	Health Information Services	Biotechnology
P/E Ratio	-10.14	-2.87
Forward P/E	303.03	N/A
PEG Ratio	-1.01	N/A
5Y EPS CAGR	-21.04%	-10.03%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	15.97%	-18.55%
P/S Ratio	0.67	26.45
P/B Ratio	1.30	1.73

Market Cap

TDOC

$1.75B

Winner

RXRX

$1.76B

Max Drawdown

TDOC

98.48%

Winner

RXRX

93.13%

Sharpe Ratio

Winner

TDOC

0.54

RXRX

-0.61

5Y Beta

Winner

TDOC

1.40

RXRX

2.63

Industry

TDOC

Health Information Services

RXRX

Biotechnology

P/E Ratio

Winner

TDOC

-10.14

RXRX

-2.87

Forward P/E

TDOC

303.03

RXRX

N/A

PEG Ratio

TDOC

-1.01

RXRX

N/A

5Y EPS CAGR

TDOC

-21.04%

Winner

RXRX

-10.03%

Debt to Equity

TDOC

0.00%

RXRX

0.00%

Free Cash Flow Yield

Winner

TDOC

15.97%

RXRX

-18.55%

P/S Ratio

Winner

TDOC

0.67

RXRX

26.45

P/B Ratio

Winner

TDOC

1.30

RXRX

1.73

TDOC vs RXRX - Historical Returns

Returns include dividend reinvestment.

Period	TDOC	RXRX
1 month	+28.10%	-3.14%
3 months	+61.83%	-13.48%
6 months	+57.63%	-33.19%
1 year	+16.57%	-51.88%
5 years(CAGR)	-42.42%	-38.84%
10 years(CAGR)	-5.39%	N/A
Max(CAGR)	-9.28%	-35.64%

Winner

TDOC

+28.10%

RXRX

-3.14%

Winner

TDOC

+61.83%

RXRX

-13.48%

Winner

TDOC

+57.63%

RXRX

-33.19%

Winner

TDOC

+16.57%

RXRX

-51.88%

5Y(CAGR)

TDOC

-42.42%

Winner

RXRX

-38.84%

10Y(CAGR)

TDOC

-5.39%

RXRX

N/A

Max(CAGR)

Winner

TDOC

-9.28%

RXRX

-35.64%

TDOC vs RXRX - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	TDOC	RXRX
2026	+37.73%	-26.67%
2025	-26.47%	-43.27%
2024	-58.55%	-31.51%
2023	-4.56%	+30.60%
2022	-75.13%	-57.24%
2021	-54.23%	-45.27%
2020	+140.16%	N/A
2019	+73.77%	N/A
2018	+36.93%	N/A
2017	+111.21%	N/A
2016	-8.28%	N/A
2015	-36.98%	N/A

TDOC vs RXRX Drawdown Comparison

The maximum drawdown for TDOC was -98.48%, occurring on Feb 12, 2026. This drawdown has not yet recovered.

The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The current TDOC drawdown is -96.70%. The current RXRX drawdown is -92.55%.

Rank	TDOC	RXRX
#1	-98.48% Feb 8, 2021 - Feb 12, 2026	-93.13% Jul 13, 2021 - Mar 30, 2026
#2	-72.72% Aug 4, 2015 - Jun 19, 2017	-38.10% Apr 29, 2021 - Jun 17, 2021
#3	-50.34% Sep 28, 2018 - Jan 6, 2020	-10.54% Apr 16, 2021 - Apr 21, 2021
#4	-30.86% Aug 4, 2020 - Jan 22, 2021	-10.45% Jun 21, 2021 - Jul 6, 2021
#5	-24.19% Sep 14, 2017 - Nov 30, 2017	-8.29% Apr 21, 2021 - Apr 29, 2021
#6	-20.08% Mar 10, 2020 - Mar 23, 2020	N/A
#7	-19.92% Jun 28, 2017 - Sep 14, 2017	N/A
#8	-19.36% Apr 27, 2020 - Jun 19, 2020	N/A
#9	-16.93% Mar 23, 2020 - Apr 15, 2020	N/A
#10	-16.53% Jan 5, 2018 - Feb 20, 2018	N/A
#11	-15.09% Nov 30, 2017 - Jan 4, 2018	N/A
#12	-14.99% Jul 19, 2018 - Aug 10, 2018	N/A
#13	-12.60% Mar 7, 2018 - May 2, 2018	N/A
#14	-10.67% Jun 20, 2018 - Jul 5, 2018	N/A
#15	-8.80% Jun 19, 2017 - Jun 23, 2017	N/A